SCHEMBL3825170

SCHEMBL3825170

O=C(OF)c1ccc(O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.60
CA2 P00918 5/20 0.60
CA12 O43570 4/20 0.60
CA7 P43166 4/20 0.60
CA9 Q16790 4/20 0.60
CA14 Q9ULX7 4/20 0.60
ESR1 P03372 5/20 0.54
ESR2 Q92731 3/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
LMNA P02545 4/20 0.52
MAPT P10636 1/20 0.52
PKM P14618 1/20 0.52
HPGD P15428 1/20 0.52
HTT P42858 1/20 0.52
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CHRM1 P11229 1/20 0.50
SLC6A2 P23975 1/20 0.50
KDR P35968 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9627860 0.89 CA1 (0.44) CA1CA2CA12CA7CA9
SCHEMBL24036696 0.80 TSHR (0.60) CA1CA2CA12CA7CA9
SCHEMBL5669277 0.79 CA1 (0.65) CA1CA2CA12CA7CA9
SCHEMBL8486618 0.79 CA1 (0.65) CA1CA2CA12CA7CA9
SCHEMBL27569922 0.78 LMNA (0.55) MEN1KMT2ALMNAMAPTPKM
SCHEMBL6426303 0.78 TDP1 (0.64) CA2MEN1KMT2ALMNAMAPT
SCHEMBL720782 0.77 LMNA (0.64) CA1CA2CA12CA7CA9
SCHEMBL247945 0.77 CA1 (0.62) CA1CA2CA12CA7CA9
SCHEMBL28840271 0.75 LMNA (0.61) CA1CA2CA12CA7CA9
SCHEMBL28762534 0.75 LMNA (0.61) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089988-B1 FLUOROPHENYL RESIN COMPOUNDS AVENTIS PHARMA INC (US) 2009-08-12 EP claimed
CN-1185259-C Fluorophenyl resin compounds AVENTIES PHARMACEUTICALS INC (US) 2005-01-19 CN claimed
US-6639023-B1 Such as 4-hydroxy, sulfonic acid or sulfonyl chloride-2,3,5,6-tetrafluorobenzamidomethyl-polystyrene resin; solid phase synthesis AVENTIS PHARMACEUTICALS INC. 2003-10-28 US claimed
CN-1306524-A Fluorophenyl resin compounds AVENTIES PHARMACEUTICALS INC (US) 2001-08-01 CN claimed
CN-109996780-A Polymerizable compound, polymerizable composition, polymerizable composition, macromolecule, optical film, optically anisotropic body, polarizing film, panel display apparatus, organic electroluminescence display device and method of manufacturing same, antireflection film and compound 日本瑞翁株式会社 2019-07-09 CN disclosed
EP-2948456-A1 BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2 GlaxoSmithKline Intellectual Property Development Limited (GB) 2015-12-02 EP disclosed
CN-102617580-B Vasopressin v1a antagonists VANTIA LTD 2015-03-04 CN disclosed
WO-2014114249-A1 BICYCLIC PYRIMIDONE COMPOUNDS AS INHIBITORS OF LP-PLA2 GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2014-07-31 WO disclosed
EP-1089988-B1 FLUOROPHENYL RESIN COMPOUNDS AVENTIS PHARMA INC (US) 2009-08-12 EP disclosed
EP-1089988-A4 FLUOROPHENYL RESIN COMPOUNDS AVENTIS PHARM PROD INC (US) 2005-01-19 EP disclosed
CN-1185259-C Fluorophenyl resin compounds AVENTIES PHARMACEUTICALS INC (US) 2005-01-19 CN disclosed
CN-1306524-A Fluorophenyl resin compounds AVENTIES PHARMACEUTICALS INC (US) 2001-08-01 CN disclosed
EP-1089988-A1 FLUOROPHENYL RESIN COMPOUNDS Aventis Pharmaceuticals Products Inc. (US) 2001-04-11 EP disclosed
WO-1999067228-A1 FLUOROPHENYL RESIN COMPOUNDS AVENTIS PHARMACEUTICALS PRODUCTS INC. (US) 1999-12-29 WO disclosed